AMY ZAGURSKI: Open Payments
NPI 1902238512 · GRAPEVINE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 38 payments from 9 companies in 2025. Trend: 2023 $1,365 · 2024 $1,671 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $355 |
| Amgen Inc. | 13 | $323 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $43 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Philips North America LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: LEQVIO, REPATHA, JARDIANCE, LifeVest, AMVUTTRA, INSPIRE, Extended Holter, FARXIGA.
Industry payments across TX — which companies pay providers there.
